COMMUNIQUÉS West-GlobeNewswire

Rentschler Biopharma appoints Dr. Torsten Woehr as Chief Executive Officer
01/07/2026
Laupheim, Germany, and Milford, MA, USA, July 01, 2026 (GLOBE NEWSWIRE) -- Rentschler Biopharma appoints Dr. Torsten Woehr as Chief Executive Officer Dr. Torsten Woehr brings over 25 years of CDMO experience with strong [...]
Applied Biologics Announces Expanded Strategic Focus on Surgical Applications of XWRAP®
01/07/2026
SCOTTSDALE, Ariz., July 01, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced an [...]
How Meaningful Work Supports Long-Term Sobriety
01/07/2026
San Diego-based Shoreline Recovery Center highlights the role employment plays in rebuilding confidence, purpose and stability following addiction treatment San Diego, CA, July 01, 2026 (GLOBE NEWSWIRE) -- For many [...]
Managing Mental Health During the Summer
01/07/2026
Park Mental Health experts share strategies for how to protect mental, emotional wellness and manage the busy season San Diego, CA, July 01, 2026 (GLOBE NEWSWIRE) -- Summer is officially here and families are busy [...]
Compass Health recognized as a Quasquicentennial Corporation, marking 125 Years of service in Northwest Washington
01/07/2026
As America celebrates 250 years, the community behavioral health nonprofit has operated for half of the nation’s existence EVERETT, Wash., July 01, 2026 (GLOBE NEWSWIRE) -- Compass Health is proud to announce its [...]
Safe Legal Steroid Alternatives: CrazyBulk Announces 2026 Legal Steroids For Muscle Growth and Strength Available In USA
01/07/2026
Discover CrazyBulk's safe legal steroid alternatives designed to support muscle growth, bulking, cutting, strength, and bodybuilding with science-inspired formulas. New York City, July 01, 2026 (GLOBE NEWSWIRE) -- In [...]
PolarityBio Announces Submission of its Biologics License Application for SkinTE® for the Treatment of Wagner Grade 1 Diabetic Foot Ulcers
01/07/2026
SkinTE ® would be the first new biologic commercially available in the U.S. for the treatment of a common chronic wound indication in nearly 30 years, if approved. SkinTE ® is a first-in-class autologous cutaneous [...]
Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences
01/07/2026
BEDFORD, Mass., July 01, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation [...]
Stryker to announce second quarter 2026 financial results
01/07/2026
Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026 , to discuss its second quarter 2026 financial results. The live [...]
LiveWorld Names Rob Thomas Vice President, Creative Director to Support Growing Healthcare Creative Practice
01/07/2026
Veteran healthcare creative leader brings deep pharmaceutical expertise and AI-driven innovation to expand agency capabilities CAMPBELL, Calif. and NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC [...]
INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion
01/07/2026
Secures Global Framework for Composition-of-Matter and Method-of-Treatment Claims Covering Lead Program Ebstrocel for Epidermolysis Bullosa and Next-Generation Engineered Modalities Extending to 2045 BOCA RATON, Fla., [...]
Harrow Announces Commercial Launch of BYOOVIZ® in the United States
01/07/2026
Expands Harrow's Growing Retina Portfolio with an Interchangeable Ranibizumab Biosimilar NASHVILLE, Tenn., July 01, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management [...]
Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease
01/07/2026
Predominantly third-line pancreatic cancer patients demonstrated durable survival despite advanced disease; patient who received Namodenoson as second-line therapy remains alive more than 18 months Ramat Gan, Israel, [...]
Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director
01/07/2026
Neil Gallagher, MD, PhD, joins with over 25 years clinical development experience, having contributed to multiple commercial therapeutics across haematology and oncology His appointment will strengthen Step Pharma’s [...]
Creative Medical Technology Holdings Issues Mid-Year Update
01/07/2026
Highlights Significant Clinical, Regulatory, and Strategic Progress, Supported by a Disciplined Capital Allocation Strategy PHOENIX, July 01, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: [...]
Seer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into Nanomics
01/07/2026
Seer's particle-based proteomics IP withstands challenges in both Europe and the United States REDWOOD CITY, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, [...]
Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL®
01/07/2026
-- Expands Patient Access to Non-Opioid Postsurgical Pain Management Across Outpatient Settings -- BRISBANE, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its [...]
JenaValve Recaps Key Highlights Including Late-Breaking Clinical Data from New York Valves 2026
01/07/2026
New Evidence Further Defines Distinct Clinical Considerations for Transcatheter Aortic Valve Replacement (TAVR) in Aortic Regurgitation (AR) and Advances Understanding of the Trilogy ® System in Patients with Left [...]
Ocugen to Participate in Upcoming July Industry Conferences
01/07/2026
MALVERN, Pa., July 01, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will [...]

Pages